Skip to content
Open access

529. **Rafaelsen Award Presentation** Cognitive function and the risk of later onset of depression in healthy individuals: a 10-year longitudinal study

Sep 2026 · International Journal of Neuropsychopharmacology · Vol 29, pp. i47 - i48 · 0 citations

Abstract

Abstract Background Cognitive impairments are common in individuals with depression, but their role in the etiology of the disorder remains unclear. Aims & Objectives In this 10-year longitudinal study, we tested whether cognitive function is associated with a risk for developing future first-episode depression in individuals without prior psychiatric diagnoses. Method Individuals without prior neurological or psychiatric illnesses (n=372) completed the Symbol digit Modalities Test (SDMT) and the Letter-Number Sequencing (LNS) test, which assess processing speed and working memory, respectively. Cognitive data were linked to future depression diagnoses and antidepressant redemption records from the Danish National Registers. Cox regression analyses examined the relation between neurocognitive function and future depression risk over 5 years and 10 years, while controlling for age, sex, personality risk factors, familial risk of depression, and calendar year of cognitive assessment. Results The number of individuals who developed depression or had antidepressants prescribed for depression were 8 (5 women) and 13 (8 women) within 5 and 10 years, respectively. Lower SDMT score was associated with an elevated risk for depression (5 years: HR=1.14 CI [1.02-1.25], p=0.018; 10 years: HR=1.06, CI [1.00-1.14], p=0.042), while lower LNS score was not (5 years: HR=0.81, CI [0.57-1.50], p=0.24; 10 years: HR=0.99, CI [0.76-1.28], p=0.91). Conversion of SDMT scores to z-scores using normative data for evaluating potential clinical significance, revealed that individuals with z=-2 were at the greatest risk of developing depression. Discussion & Conclusions This study provides evidence that lower SDMT scores, a clinically used cognitive test that primarily assesses processing speed but also involves attention, recognition, and working memory, and which may be indicative of general cognitive capacity, are a risk factor for the onset of depression later in life. The findings raise the question if pro-cognitive interventions could be valuable for reducing the burden of depression in the general population.

Read PDF

Similar papers

Open access Sep 2026

674. Cognitive and neurobiological indicators of risk and prognosis in mood disorders

Abstract Background Mood disorders are major contributors to the global burden of disease. There is a critical need for reliable markers that can identify individuals at elevated risk for developing mood disorders and predict poor prognosis among those already affected, in order to guide personalized interventions. Aim...

A. Sankar, B. Ozenne, V. Dam et al. · 0 citations
Open access Sep 2026

Cognitive Reserve as a Stratification Factor for Cognitive Impairment and Disease Progression in Major Depressive Disorder.

The moderating effect of CR on the brain network-cognition association provides a neurobiological rationale for this vulnerability and supports incorporating CR into routine clinical assessment to guide risk stratification and personalized treatment planning.

M. Gruber, Henrike Renaud, M. Mauritz et al. · 0 citations
Open access Sep 2026

Neurocognitive profiles in early childhood in relation to clinical and functional outcomes in middle childhood in offspring at familial high-risk of schizophrenia or bipolar disorder: The Danish High-Risk and Resilience Study.

A significantly impaired neurocognitive profile in early childhood confers risk for detrimental clinical and functional outcomes in middle childhood beyond that which can be attributed to pre-existing clinical and functional states and constitutes a cross-diagnostic, neurodevelopmental risk marker in these FHR-groups.

N. Hemager, J. Jepsen, A. Greve et al. · 0 citations
Open access Sep 2026

577. **Rafaelsen Award Presentation** Association between cortical serotonin release and cognitive function in schizophrenia: an in vivo [11C]Cimbi-36 PET study with a d-Amphetamine challenge

This is the first direct assessment of the relationship between serotonin release and cognition in schizophrenia and shows that neocortical serotonin release is directly associated with general intellectual function in schizophrenia.

M. Osugo, T. R. Marques, M. Veronese et al. · 0 citations
Open access Sep 2026

Minor depressive symptoms are associated with reduced memory performance across the adult lifespan.

Individuals with a diagnosis of major depressive disorder exhibit cognitive difficulties. However, the effects of subclinical or subthreshold depressive symptoms on cognition are less known. The aim of the present cross-sectional study was to determine the possible influence of minor depressive symptoms on working memo...

S. Cansino, Frine Torres-Trejo, Cinthya Estrada-Manilla et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.